Found: 51
Select item for more details and to access through your institution.
A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 3, p. 439, doi. 10.1007/s00432-017-2572-6
- By:
- Publication type:
- Article
WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System.
- Published in:
- Scientific Data, 2022, v. 9, n. 1, p. 1, doi. 10.1038/s41597-022-01823-3
- By:
- Publication type:
- Article
Multiomics Analysis Reveals the Prognostic Non-tumor Cell Landscape in Glioblastoma Niches.
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.741325
- By:
- Publication type:
- Article
Temporal and spatial stability of the EM/PM molecular subtypes in adult diffuse glioma.
- Published in:
- Frontiers of Medicine, 2023, v. 17, n. 2, p. 240, doi. 10.1007/s11684-022-0936-z
- By:
- Publication type:
- Article
A novel chemokine‐based signature for prediction of prognosis and therapeutic response in glioma.
- Published in:
- CNS Neuroscience & Therapeutics, 2022, v. 28, n. 12, p. 2090, doi. 10.1111/cns.13944
- By:
- Publication type:
- Article
High‐sensitive clinical diagnostic method for PTPRZ1‐MET and the characteristic protein structure contributing to ligand‐independent MET activation.
- Published in:
- CNS Neuroscience & Therapeutics, 2021, v. 27, n. 5, p. 617, doi. 10.1111/cns.13627
- By:
- Publication type:
- Article
A novel DNA repair‐related nomogram predicts survival in low‐grade gliomas.
- Published in:
- CNS Neuroscience & Therapeutics, 2021, v. 27, n. 2, p. 186, doi. 10.1111/cns.13464
- By:
- Publication type:
- Article
RGS16 promotes glioma progression and serves as a prognostic factor.
- Published in:
- CNS Neuroscience & Therapeutics, 2020, v. 26, n. 8, p. 791, doi. 10.1111/cns.13382
- By:
- Publication type:
- Article
An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas.
- Published in:
- 2022
- By:
- Publication type:
- journal article
In Vitro Validation of the Therapeutic Potential of Dendrimer-Based Nanoformulations against Tumor Stem Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 10, p. 5691, doi. 10.3390/ijms23105691
- By:
- Publication type:
- Article
FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomide.
- Published in:
- BMC Neurology, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12883-021-02476-2
- By:
- Publication type:
- Article
Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.800928
- By:
- Publication type:
- Article
Clinical characteristics and survival of glioblastoma complicated with non-central nervous system tumors.
- Published in:
- Chinese Neurosurgical Journal, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s41016-022-00312-1
- By:
- Publication type:
- Article
New-Onset Postoperative Seizures in Patients With Diffuse Gliomas: A Risk Assessment Analysis.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.682535
- By:
- Publication type:
- Article
Stalled oligodendrocyte differentiation in IDH-mutant gliomas.
- Published in:
- Genome Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13073-023-01175-6
- By:
- Publication type:
- Article
Glioma-related epilepsy in patients with diffuse high-grade glioma after the 2016 WHO update: seizure characteristics, risk factors, and clinical outcomes.
- Published in:
- Journal of Neurosurgery, 2022, v. 136, n. 1, p. 67, doi. 10.3171/2020.12.JNS203351
- By:
- Publication type:
- Article
Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3859, doi. 10.3390/cancers12123859
- By:
- Publication type:
- Article
Uronic acid metabolic process-related gene expression-based signature predicts overall survival of glioma.
- Published in:
- Bioscience Reports, 2021, v. 41, n. 1, p. 1, doi. 10.1042/BSR20203051
- By:
- Publication type:
- Article
PTBP1-mediated repression of neuron-specific CDC42 splicing constitutes a genomic alteration-independent, developmentally conserved vulnerability in IDH-wildtype glioblastoma.
- Published in:
- Functional & Integrative Genomics, 2024, v. 24, n. 4, p. 1, doi. 10.1007/s10142-024-01412-0
- By:
- Publication type:
- Article
Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 6, p. 1955, doi. 10.1002/cam4.2754
- By:
- Publication type:
- Article
NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.751183
- By:
- Publication type:
- Article
TREM2 is associated with tumor immunity and implies poor prognosis in glioma.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2022.1089266
- By:
- Publication type:
- Article
GENE-40. MEGF10, A GLIOMA SURVIVAL ASSOCIATED MOLECULAR SIGNATURE PREDICTS IDH MUTATION STATUS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi112, doi. 10.1093/neuonc/noy148.466
- By:
- Publication type:
- Article
Radiotherapy delays malignant transformation and prolongs survival in patients with IDH-mutant gliomas.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 10, p. 1477, doi. 10.20892/j.issn.2095-3941.2022.0472
- By:
- Publication type:
- Article
Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011-2017): a multicenter retrospective study from CGGA.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 10, p. 1460, doi. 10.20892/j.issn.2095-3941.2022.0469
- By:
- Publication type:
- Article
Comparative profiling of immune genes improves the prognoses of lower grade gliomas.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 4, p. 533, doi. 10.20892/j.issn.2095-3941.2021.0173
- By:
- Publication type:
- Article
Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma.
- Published in:
- Cancer Biology & Medicine, 2021, v. 18, n. 1, p. 271, doi. 10.20892/j.issn.2095-3941.2020.0179
- By:
- Publication type:
- Article
Redox Regulator GLRX Is Associated With Tumor Immunity in Glioma.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.580934
- By:
- Publication type:
- Article
Single-Cell RNA-Sequencing Shift in the Interaction Pattern Between Glioma Stem Cells and Immune Cells During Tumorigenesis.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.581209
- By:
- Publication type:
- Article
MET fusions and splicing variants is a strong adverse prognostic factor in astrocytoma, isocitrate dehydrogenase mutant.
- Published in:
- Brain Pathology, 2024, v. 34, n. 3, p. 1, doi. 10.1111/bpa.13198
- By:
- Publication type:
- Article
MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status.
- Published in:
- Disease Markers, 2018, p. 1, doi. 10.1155/2018/5975216
- By:
- Publication type:
- Article
A novel methylation signature predicts radiotherapy sensitivity in glioma.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-77259-9
- By:
- Publication type:
- Article
A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expression.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-75574-9
- By:
- Publication type:
- Article
A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-72480-y
- By:
- Publication type:
- Article
ABCC8 mRNA expression is an independent prognostic factor for glioma and can predict chemosensitivity.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-69676-7
- By:
- Publication type:
- Article
ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 12, p. 1, doi. 10.1038/s41419-018-1232-3
- By:
- Publication type:
- Article
Trogocytosis of CAR molecule regulates CAR-T cell dysfunction and tumor antigen escape.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01708-w
- By:
- Publication type:
- Article
High-dose radiation associated with improved survival in IDH-wildtype low-grade glioma.
- Published in:
- Chinese Neurosurgical Journal, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s41016-021-00239-z
- By:
- Publication type:
- Article
A novel gene signature based on five immune checkpoint genes predicts the survival of glioma.
- Published in:
- Chinese Neurosurgical Journal, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s41016-020-00220-2
- By:
- Publication type:
- Article
Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma.
- Published in:
- Cancer Communications, 2023, v. 43, n. 12, p. 1326, doi. 10.1002/cac2.12502
- By:
- Publication type:
- Article
Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma.
- Published in:
- Oncologist, 2021, v. 26, n. 8, p. e1460, doi. 10.1002/onco.13750
- By:
- Publication type:
- Article
Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapy.
- Published in:
- Oncology Letters, 2019, v. 18, n. 6, p. 6509, doi. 10.3892/ol.2019.11017
- By:
- Publication type:
- Article
Progenitor cells derived from gene‐engineered human induced pluripotent stem cells as synthetic cancer cell alternatives for in vitro pharmacology.
- Published in:
- Biotechnology Journal, 2022, v. 17, n. 6, p. 1, doi. 10.1002/biot.202100693
- By:
- Publication type:
- Article
Association of high‐dose radiotherapy with improved survival in patients with newly diagnosed low‐grade gliomas.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 5, p. 1085, doi. 10.1002/cncr.34028
- By:
- Publication type:
- Article
Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma.
- Published in:
- Cancer Cell International, 2018, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12935-018-0603-2
- By:
- Publication type:
- Article
Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples.
- Published in:
- Cancer Science, 2022, v. 113, n. 2, p. 756, doi. 10.1111/cas.15236
- By:
- Publication type:
- Article
Identification of an ATP metabolism‐related signature associated with prognosis and immune microenvironment in gliomas.
- Published in:
- Cancer Science, 2020, v. 111, n. 7, p. 2325, doi. 10.1111/cas.14484
- By:
- Publication type:
- Article
Genetic and clinical characterization of B7‐H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
- Published in:
- Cancer Science, 2018, v. 109, n. 9, p. 2697, doi. 10.1111/cas.13744
- By:
- Publication type:
- Article
Poliovirus receptor–based chimeric antigen receptor T cells combined with NK-92 cells exert potent activity against glioblastoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 3, p. 389, doi. 10.1093/jnci/djad226
- By:
- Publication type:
- Article
Carbonic Anhydrase XII is a Clinically Significant, Molecular Tumor-Subtype Specific Therapeutic Target in Glioma with the Potential to Combat Invasion of Brain Tumor Cells.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 1707, doi. 10.2147/OTT.S300623
- By:
- Publication type:
- Article